We are live on ! Find out more
C

Chescapmanager Portfolio holdings

AUM $1.17B Turnover 10.34%
1-Year Est. Return 42.44%
This Fund
S&P 500
This Quarter Est. Return
+12.58%
1 Year Est. Return
+42.44%
3 Year Est. Return
+202.08%
5 Year Est. Return
+174.76%
10 Year Est. Return
–
AUM
$680M
AUM Growth
-$22.8M
Cap. Flow
+$19.8M
Cap. Flow %
2.92%
Top 10 Hldgs %
66.57%
Holding
38
New
6
Increased
8
Reduced
4
Closed
6
Avg Time Held Equity + Options
1.5 years
Top 10 Avg Time Held Equity + Options
0.7 years
Top 20 Avg Time Held Equity + Options
1.3 years
Avg Time Held Equity only
1.7 years
Top 10 Avg Time Held Equity only
1.3 years
Top 20 Avg Time Held Equity only
1.6 years

Sector Composition

Rank Sector Weight
1 Healthcare 31.86%
2 Miscellaneous 26.78%
3 Consumer Discretionary 20.12%
4 Industrials 6.33%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$161M 23.66%
500,000
– –
2019 Q1
3 quarters
CRON icon
2
Cronos Group
CRON
$1.22B
$68.1M 10.01%
8,873,890
+381,663
+4% +$2.92M
2018 Q1
7 quarters
AGN
3
DELISTED
Allergan plc
AGN
$37.7M 5.54%
197,000
– –
2016 Q4
12 quarters
WSC icon
4
WillScot Mobile Mini Holdings
WSC
$3.32B
$34M 5%
1,837,306
– –
2017 Q3
9 quarters
MGM icon
5
MGM Resorts International
MGM
$7.58B
$29.2M 4.3%
878,052
-10,000
-1% -$305K
2016 Q4
12 quarters
AMZN icon
6
Amazon
AMZN
$2.6T
$27.7M 4.08%
300,000
+40,000
+15% +$3.54M
2016 Q4
12 quarters
GOOGL icon
7
Alphabet (Google) Class A
GOOGL
$3.44T
$25.4M 3.74%
380,000
– –
2016 Q4
12 quarters
TBPH icon
8
DELISTED
Theravance Biopharma
TBPH
$24.6M 3.61%
949,006
+351,422
+59% +$6.83M
2016 Q4
12 quarters
TIF
9
DELISTED
Tiffany & Co.
TIF
$22.7M 3.34%
+170,000
New +$20.1M
2019 Q4
0 quarters
CI icon
10
Cigna
CI
$78.8B
$22.4M 3.3%
109,693
-10,000
-8% -$1.83M
2018 Q1
7 quarters
BMY icon
11
Bristol-Myers Squibb
BMY
$128B
$21.9M 3.22%
+340,852
New +$19.5M
2019 Q4
0 quarters
NOMD icon
12
Nomad Foods
NOMD
$1.68B
$21.9M 3.22%
978,043
+52,461
+6% +$1.07M
2016 Q4
12 quarters
TVRD icon
13
Tvardi Therapeutics
TVRD
$10.6M
$20.9M 3.08%
36,103
+1,597
+5% +$1.12M
2016 Q4
12 quarters
CNC icon
14
Centene
CNC
$33.9B
$20.9M 3.08%
332,777
– –
2019 Q1
3 quarters
CZR icon
15
DELISTED
Caesars Entertainment Corporation
CZR
$20.3M 2.99%
1,494,458
– –
2018 Q2
6 quarters
EXP icon
16
Eagle Materials
EXP
$5.63B
$17.5M 2.58%
193,425
-111,646
-37% -$10.2M
2016 Q4
12 quarters
MTN icon
17
Vail Resorts
MTN
$5.42B
$14.4M 2.12%
60,000
– –
2016 Q4
12 quarters
DISH
18
CALL
DELISTED
DISH Network Corp.
DISH
$11M 1.62%
310,000
– –
2019 Q2
2 quarters
PENN icon
19
PENN Entertainment
PENN
$2.13B
$10.1M 1.48%
394,289
– –
2017 Q4
8 quarters
DISH
20
DELISTED
DISH Network Corp.
DISH
$9.8M 1.43%
274,969
+105,569
+62% +$3.66M
2017 Q1
11 quarters
DLTR icon
21
Dollar Tree
DLTR
$25.1B
$8.94M 1.31%
+95,000
New +$10M
2019 Q4
0 quarters
AXTA icon
22
Axalta
AXTA
$7.29B
$8.84M 1.3%
290,691
– –
2019 Q2
2 quarters
NLSN
23
DELISTED
Nielsen Holdings plc
NLSN
$8.64M 1.27%
425,610
– –
2018 Q3
5 quarters
CZR icon
24
Caesars Entertainment
CZR
$5.93B
$7.16M 1.05%
120,000
– –
2019 Q2
2 quarters
CZR icon
25
CALL
Caesars Entertainment
CZR
$5.93B
$5.96M 0.88%
100,000
– –
2019 Q2
2 quarters

Similar funds

Chescapmanager's Q4 2019 Portfolio in Review

As of Q4 2019, Chescapmanager held 38 positions worth $680M, down 3.2% from $703M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Chescapmanager's Q4 2019 filing shows 6 new, 8 increased, 4 reduced and 6 closed positions. Its largest new stake was Tiffany & Co.: 170,000 shares worth $22.7M. The largest sale was Celgene Corp, an estimated $28.4M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

  • Chescapmanager's largest Q4 2019 buy was Tiffany & Co.: 170,000 shares worth $22.7M.
  • Chescapmanager added most to Theravance Biopharma in Q4 2019, an estimated $6.83M increase.
  • Chescapmanager's biggest Q4 2019 reduction was Eagle Materials, cutting an estimated $10.2M.
  • Chescapmanager fully exited Celgene Corp in Q4 2019, selling an estimated $28.4M.
  • Chescapmanager's ten largest holdings make up 67% of its $680M portfolio in Q4 2019.
  • Chescapmanager opened 6 new positions and closed 6 in Q4 2019.
  • Chescapmanager's portfolio value fell 3.2% quarter-over-quarter to $680M.

Based on Chescapmanager's 13F filing for Q4 2019, filed 12 Feb 2020.